Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Unconsented genetic testing in psychiatry: an (almost) no go?

Luykx JJ, van der Spek R, van Veen S, Lo-A-Foe W, Giesbertz NAA, Bredenoord AL, Palmboom GG.

Lancet Psychiatry. 2019 Aug;6(8):641-642. doi: 10.1016/S2215-0366(19)30206-8. No abstract available.

PMID:
31327434
2.

Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort).

Pandit R, Cianci D, Ter Hark SE, Winter-van Rossum I, Ebdrup BH, Broberg BV, Garcia-Portilla MP, Bobes J, Vinkers CH, Kahn RS, Guloksuz S, Huitema ADR, Luykx JJ.

Acta Psychiatr Scand. 2019 Jul 19. doi: 10.1111/acps.13074. [Epub ahead of print]

PMID:
31323113
3.

[Reaction on 'Hypomania induced by intranasal corticosteroid fluticasone spray'].

Luykx JJ, Jacobs G, Vinkers CH.

Tijdschr Psychiatr. 2019;61(5):362-364. Dutch.

4.

Hypomanie geïnduceerd door intranasaal corticosteroïd fluticasonspray.

Luykx JJ, Jacobs G, Vinkers CH.

Tijdschr Psychiatr. 2019;61(5):362-364. Dutch.

5.

Antipsychotic Exposure in Pregnancy and the Risk of Gestational Diabetes: A Systematic Review and Meta-analysis.

Kucukgoncu S, Guloksuz S, Celik K, Bahtiyar MO, Luykx JJ, Rutten BPF, Tek C.

Schizophr Bull. 2019 Jun 5. pii: sbz058. doi: 10.1093/schbul/sbz058. [Epub ahead of print]

PMID:
31167033
6.

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription.

Okhuijsen-Pfeifer C, Cohen D, Bogers JPAM, de Vos CMH, Huijsman EAH, Kahn RS, Luykx JJ.

Brain Behav. 2019 Jul;9(7):e01318. doi: 10.1002/brb3.1318. Epub 2019 May 29.

7.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J.

World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629.

8.

Genetic cross-disorder analysis in psychiatry: from methodology to clinical utility.

Schijven D, Veldink JH, Luykx JJ.

Br J Psychiatry. 2019 Apr 1:1-4. doi: 10.1192/bjp.2019.72. [Epub ahead of print]

PMID:
30931869
9.

The effect of genetic vulnerability and military deployment on the development of post-traumatic stress disorder and depressive symptoms.

Schür RR, Schijven D, Boks MP, Rutten BPF, Stein MB, Veldink JH, Joëls M, Geuze E, Vermetten E, Luykx JJ, Vinkers CH.

Eur Neuropsychopharmacol. 2019 Mar;29(3):405-415. doi: 10.1016/j.euroneuro.2018.12.009. Epub 2019 Feb 14.

PMID:
30773389
10.

The Alkaline Phosphatase (ALPL) Locus Is Associated with B6 Vitamer Levels in CSF and Plasma.

Loohuis LM, Albersen M, de Jong S, Wu T, Luykx JJ, Jans JJM, Verhoeven-Duif NM, Ophoff RA.

Genes (Basel). 2018 Dec 22;10(1). pii: E8. doi: 10.3390/genes10010008.

11.

Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.

Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2019 Jan;271:421-427. doi: 10.1016/j.psychres.2018.11.071. Epub 2018 Dec 3.

PMID:
30537664
12.

Persistent catatonia following epileptic seizures: a case report and systematic literature search.

Verbraeken R, Luykx JJ.

BMC Psychiatry. 2018 Oct 29;18(1):350. doi: 10.1186/s12888-018-1935-0.

13.

Painful Petechiae Emerging During Electroconvulsive Therapy.

Luykx JJ, Veltkamp R, Feenstra N, Bolt M, van Waarde J.

J ECT. 2019 Jun;35(2):71-72. doi: 10.1097/YCT.0000000000000549. No abstract available.

PMID:
30346350
14.

Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.

Okhuijsen-Pfeifer C, Huijsman EAH, Hasan A, Sommer IEC, Leucht S, Kahn RS, Luykx JJ.

Acta Psychiatr Scand. 2018 Oct;138(4):281-288. doi: 10.1111/acps.12954. Epub 2018 Sep 14.

15.

[Pancreatitis and thrombotic thrombocytopenic purpura caused by quetiapine-induced hypertriglyceridemia].

Luykx JJ, Huygh J, Daems J, Schoonheydt K.

Tijdschr Psychiatr. 2018;60(8):552-556. Dutch.

16.

The role of genetic variation of human metabolism for BMI, mental traits and mental disorders.

Hebebrand J, Peters T, Schijven D, Hebebrand M, Grasemann C, Winkler TW, Heid IM, Antel J, Föcker M, Tegeler L, Brauner L, Adan RAH, Luykx JJ, Correll CU, König IR, Hinney A, Libuda L.

Mol Metab. 2018 Jun;12:1-11. doi: 10.1016/j.molmet.2018.03.015. Epub 2018 Apr 3.

17.

Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling.

Schijven D, Kofink D, Tragante V, Verkerke M, Pulit SL, Kahn RS, Veldink JH, Vinkers CH, Boks MP, Luykx JJ.

Schizophr Res. 2018 Sep;199:195-202. doi: 10.1016/j.schres.2018.03.032. Epub 2018 Apr 11.

PMID:
29653892
18.

[In- and out-of-hospital emergency psychiatry: what is the best approach?]

Luykx JJ, Tijdink JK, Tempelaar W, Vinkers CH, de Witte L.

Ned Tijdschr Geneeskd. 2018;162:D2387. Dutch.

PMID:
29451111
19.

Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs.

Lancee M, Lemmens CMC, Kahn RS, Vinkers CH, Luykx JJ.

Transl Psychiatry. 2017 Sep 12;7(9):e1232. doi: 10.1038/tp.2017.203. Review.

20.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

21.

The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis.

Luykx JJ, Broersen JL, de Leeuw M.

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):214-224. doi: 10.1016/j.neubiorev.2017.01.006. Epub 2017 Jan 16. Review.

PMID:
28104410
22.

Peripheral blood gene expression profiles linked to monoamine metabolite levels in cerebrospinal fluid.

Luykx JJ, Olde Loohuis LM, Neeleman M, Strengman E, Bakker SC, Lentjes E, Borgdorff P, van Dongen EP, Bruins P, Kahn RS, Horvath S, de Jong S, Ophoff RA.

Transl Psychiatry. 2016 Dec 13;6(12):e983. doi: 10.1038/tp.2016.245.

23.

DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients.

Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS.

Schizophr Bull. 2016 May;42(3):843-50. doi: 10.1093/schbul/sbv166. Epub 2015 Nov 23.

24.

Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.

Luykx JJ, Bakker SC, Visser WF, Verhoeven-Duif N, Buizer-Voskamp JE, den Heijer JM, Boks MP, Sul JH, Eskin E, Ori AP, Cantor RM, Vorstman J, Strengman E, DeYoung J, Kappen TH, Pariama E, van Dongen EP, Borgdorff P, Bruins P, de Koning TJ, Kahn RS, Ophoff RA.

Mol Psychiatry. 2015 Dec;20(12):1557-64. doi: 10.1038/mp.2014.190. Epub 2015 Feb 10.

PMID:
25666758
25.

Vitamin B-6 vitamers in human plasma and cerebrospinal fluid.

Albersen M, Bosma M, Luykx JJ, Jans JJ, Bakker SC, Strengman E, Borgdorff PJ, Keijzers PJ, van Dongen EP, Bruins P, de Sain-van der Velden MG, Visser G, Knoers NV, Ophoff RA, Verhoeven-Duif NM.

Am J Clin Nutr. 2014 Aug;100(2):587-92. doi: 10.3945/ajcn.113.082008. Epub 2014 May 7.

PMID:
24808484
26.

Multisystem component phenotypes of bipolar disorder for genetic investigations of extended pedigrees.

Fears SC, Service SK, Kremeyer B, Araya C, Araya X, Bejarano J, Ramirez M, Castrillón G, Gomez-Franco J, Lopez MC, Montoya G, Montoya P, Aldana I, Teshiba TM, Abaryan Z, Al-Sharif NB, Ericson M, Jalbrzikowski M, Luykx JJ, Navarro L, Tishler TA, Altshuler L, Bartzokis G, Escobar J, Glahn DC, Ospina-Duque J, Risch N, Ruiz-Linares A, Thompson PM, Cantor RM, Lopez-Jaramillo C, Macaya G, Molina J, Reus VI, Sabatti C, Freimer NB, Bearden CE.

JAMA Psychiatry. 2014 Apr;71(4):375-87. doi: 10.1001/jamapsychiatry.2013.4100. Erratum in: JAMA Psychiatry. 2016 Jul 1;73(7):758-9. JAMA Psychiatry. 2016 Jul 1;73(7):759.

27.

Seasonal changes in gene expression represent cell-type composition in whole blood.

De Jong S, Neeleman M, Luykx JJ, ten Berg MJ, Strengman E, Den Breeijen HH, Stijvers LC, Buizer-Voskamp JE, Bakker SC, Kahn RS, Horvath S, Van Solinge WW, Ophoff RA.

Hum Mol Genet. 2014 May 15;23(10):2721-8. doi: 10.1093/hmg/ddt665. Epub 2014 Jan 7.

28.

Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR.

Luykx JJ, Bakker SC, van Geloven N, Eijkemans MJ, Horvath S, Lentjes E, Boks MP, Strengman E, DeYoung J, Buizer-Voskamp JE, Cantor RM, Lu A, van Dongen EP, Borgdorff P, Bruins P, Kahn RS, Ophoff RA.

Transl Psychiatry. 2013 Oct 8;3:e311. doi: 10.1038/tp.2013.84.

29.

The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.

Vinkers CH, Van Gastel WA, Schubart CD, Van Eijk KR, Luykx JJ, Van Winkel R, Joëls M, Ophoff RA, Boks MP; Genetic Risk and OUtcome of Psychosis (GROUP) Investigators, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D.

Schizophr Res. 2013 Oct;150(1):303-11. doi: 10.1016/j.schres.2013.07.020. Epub 2013 Aug 15.

30.

NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies.

Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS.

Neurosci Biobehav Rev. 2013 Sep;37(8):1587-96. doi: 10.1016/j.neubiorev.2013.06.007. Epub 2013 Jun 18.

PMID:
23792047
31.

Agitation after minor trauma: combativeness as a cardinal catatonic feature.

Luykx JJ, Post EH, van der Erf M, Van Hecke J.

BMJ Case Rep. 2013 Jun 3;2013. pii: bcr2012008217. doi: 10.1136/bcr-2012-008217.

32.

D-amino acid aberrations in cerebrospinal fluid and plasma of smokers.

Luykx JJ, Bakker SC, van Boxmeer L, Vinkers CH, Smeenk HE, Visser WF, Verhoeven-Duif NM, Strengman E, Buizer-Voskamp JE, de Groene L, van Dongen EP, Borgdorff P, Bruins P, de Koning TJ, Kahn RS, Ophoff RA.

Neuropsychopharmacology. 2013 Sep;38(10):2019-26. doi: 10.1038/npp.2013.103. Epub 2013 Apr 24.

33.

Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.

Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, van Amerongen M, van Dongen EP, Keijzers P, Kappen T, Borgdorff P, Bruins P, Derks EM, Kahn RS, Ophoff RA.

Mol Psychiatry. 2014 Feb;19(2):228-34. doi: 10.1038/mp.2012.183. Epub 2013 Jan 15.

PMID:
23319000
34.

Psychotic symptoms after combined metronidazole-disulfiram use.

Luykx JJ, Vis R, Tijdink JK, Dirckx M, Van Hecke J, Vinkers CH.

J Clin Psychopharmacol. 2013 Feb;33(1):136-7. doi: 10.1097/01.jcp.0000426185.68487.9a. No abstract available.

PMID:
23288239
35.

BDNF Val66Met homozygosity does not influence plasma BDNF levels in healthy human subjects.

Luykx JJ, Boks MP, Breetvelt EJ, Aukes MF, Strengman E, da Pozzo E, Dell'osso L, Marazziti D, van Leeuwen A, Vreeker A, Abramovic L, Martini C, Numans ME, Kahn RS, Ophoff RA.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:185-7. doi: 10.1016/j.pnpbp.2012.12.017. Epub 2012 Dec 23.

PMID:
23269345
36.

[Choosing the correct benzodiazepine: mechanism of action and pharmacokinetics].

Vinkers CH, Tijdink JK, Luykx JJ, Vis R.

Ned Tijdschr Geneeskd. 2012;155(35):A4900. Review. Dutch.

PMID:
22929751
37.

A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid.

Luykx JJ, Vinkers CH, Bakker SC, Visser WF, van Boxmeer L, Strengman E, van Eijk KR, Lens JA, Borgdorff P, Keijzers P, Kappen TH, van Dongen EP, Bruins P, Verhoeven NM, de Koning TJ, Kahn RS, Ophoff RA.

Neuropsychopharmacology. 2012 Aug;37(9):2088-92. doi: 10.1038/npp.2012.57. Epub 2012 May 2.

38.

Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid.

Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, van Dongen EP, Michel B, Abramovic L, Horvath S, Kappen T, Bruins P, Keijzers P, Borgdorff P, Ophoff RA, Kahn RS.

PLoS One. 2012;7(2):e30497. doi: 10.1371/journal.pone.0030497. Epub 2012 Feb 1.

39.

The association of the alpha-5 subunit of the nicotinic acetylcholine receptor gene and the brain-derived neurotrophic factor gene with different aspects of smoking behavior.

Breetvelt EJ, Numans ME, Aukes MF, Hoeben W, Strengman E, Luykx JJ, Bakker SC, Kahn RS, Ophoff RA, Boks MP.

Psychiatr Genet. 2012 Apr;22(2):96-8. doi: 10.1097/YPG.0b013e32834c0c75.

PMID:
22008662
40.

Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.

Luykx JJ, Laban KG, van den Heuvel MP, Boks MP, Mandl RC, Kahn RS, Bakker SC.

Neurosci Biobehav Rev. 2012 Jan;36(1):198-205. doi: 10.1016/j.neubiorev.2011.05.014. Epub 2011 Jun 6. Review.

PMID:
21672551
41.

Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders.

Luykx JJ, Carpay JA.

Expert Opin Drug Saf. 2010 Jul;9(4):623-31. doi: 10.1517/14740331003739196. Review.

PMID:
20367527
42.

The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.

Luykx JJ, Boks MP, Terwindt AP, Bakker S, Kahn RS, Ophoff RA.

Eur Neuropsychopharmacol. 2010 Jun;20(6):357-68. doi: 10.1016/j.euroneuro.2010.02.008. Epub 2010 Mar 11. Review.

PMID:
20226637
43.

[Neuropsychiatric disorders. Multidisciplinary diagnosis and treatment].

Luykx JJ, Wolters FJ, Vulink NC, van der Erf M, Wokke JH, Kahn RS.

Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):75-9. Dutch. No abstract available.

PMID:
19235342

Supplemental Content

Loading ...
Support Center